NCT03435536View on ClinicalTrials.gov

Surgery Impact on Circulating Tumor DNA in Pancreatic Cancer

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

February 26, 2018

Primary Completion Date

June 20, 2022

Study Completion Date

June 20, 2022

Conditions
Resectable Pancreatic Cancer
Interventions
OTHER

Blood samples

Blood samples will be taken to analyze the circulating tumor DNA rate by NGS

Trial Locations (1)

31059

University Hospital, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT03435536 - Surgery Impact on Circulating Tumor DNA in Pancreatic Cancer | Biotech Hunter | Biotech Hunter